Atai Life Sciences
Series BAtai Life Sciences raised €38M in a Series B round in Jan 2019. The company is based in Munich, Germany. Investors in the round: Subversive Capital. Data as of 4 Nov 2026.
Amount raised
€38M
€37,554,585
Native amount
43,000,000 USD
Stage
Series B
series b
Investors
1
Provenance & confidence
High confidenceAmount
43,000,000 USD
ECB-at-date → €38M · rate 1.145 on 2018-12-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.